These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26136532)

  • 1. Renal mineralocorticoid receptor and electrolyte homeostasis.
    Terker AS; Ellison DH
    Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(9):R1068-70. PubMed ID: 26136532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of the mineralocorticoid receptor in aldosterone-dependent and aldosterone-independent regulation of ENaC in the distal nephron.
    Nesterov V; Bertog M; Canonica J; Hummler E; Coleman R; Welling PA; Korbmacher C
    Am J Physiol Renal Physiol; 2021 Sep; 321(3):F257-F268. PubMed ID: 34251271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of kidney on potassium balance and its clinical significance].
    Xie QH; Hao CM
    Sheng Li Xue Bao; 2023 Apr; 75(2):216-230. PubMed ID: 37089096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms.
    Fu Y; Vallon V
    Nephron Physiol; 2014; 128(1-2):8-16. PubMed ID: 25376899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?
    Gomez-Sanchez EP
    Trends Endocrinol Metab; 2011 May; 22(5):179-87. PubMed ID: 21429762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
    Laragh JH
    N Engl J Med; 1985 Nov; 313(21):1330-40. PubMed ID: 2932646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotic syndrome is associated with increased plasma K
    Ydegaard R; Svenningsen P; Bistrup C; Andersen RF; Stubbe J; Buhl KB; Marcussen N; Hinrichs GR; Iraqi H; Zamani R; Dimke H; Jensen BL
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1549-F1562. PubMed ID: 31566427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Pendrin in the Pathophysiology of Aldosterone-Induced Hypertension.
    Shibata S
    Am J Hypertens; 2019 Jun; 32(7):607-613. PubMed ID: 30982848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying rapid aldosterone effects in the kidney.
    Thomas W; Harvey BJ
    Annu Rev Physiol; 2011; 73():335-57. PubMed ID: 20809792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone Regulates Pendrin and Epithelial Sodium Channel Activity through Intercalated Cell Mineralocorticoid Receptor-Dependent and -Independent Mechanisms over a Wide Range in Serum Potassium.
    Pham TD; Verlander JW; Wang Y; Romero CA; Yue Q; Chen C; Thumova M; Eaton DC; Lazo-Fernandez Y; Wall SM
    J Am Soc Nephrol; 2020 Mar; 31(3):483-499. PubMed ID: 32054691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone and its mechanism of action: more questions than answers.
    Fuller PJ
    Aust N Z J Med; 1995 Dec; 25(6):800-7. PubMed ID: 8770356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epithelial sodium channel and the control of sodium balance.
    Schild L
    Biochim Biophys Acta; 2010 Dec; 1802(12):1159-65. PubMed ID: 20600867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.
    Rafiq K; Hitomi H; Nakano D; Nishiyama A
    J Pharmacol Sci; 2011; 115(1):1-7. PubMed ID: 21186336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
    Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
    Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mineralocorticoid receptor: a new player controlling energy homeostasis.
    Kuhn E; Lombès M
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):59-69. PubMed ID: 25436733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor and NaCl transport mechanisms in the renal distal nephron.
    Shibata S
    J Endocrinol; 2017 Jul; 234(1):T35-T47. PubMed ID: 28341694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage.
    Waanders F; de Vries LV; van Goor H; Hillebrands JL; Laverman GD; Bakker SJ; Navis G
    Curr Vasc Pharmacol; 2011 Sep; 9(5):594-605. PubMed ID: 21529330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Context-dependent mechanisms modulating aldosterone signaling in the kidney.
    Shibata S
    Clin Exp Nephrol; 2016 Oct; 20(5):663-670. PubMed ID: 26846783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
    Bauersachs J; Jaisser F; Toto R
    Hypertension; 2015 Feb; 65(2):257-63. PubMed ID: 25368026
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of distal tubule sodium transport: mechanisms and roles in homeostasis and pathophysiology.
    Pearce D; Manis AD; Nesterov V; Korbmacher C
    Pflugers Arch; 2022 Aug; 474(8):869-884. PubMed ID: 35895103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.